amantadine has been researched along with ergoline in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (75.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hungerbühler, JP; Regli, F | 1 |
Durand, JP; Gautier, JC | 1 |
Dostálová, K; Hrbek, J; Komárková, A; Komenda, S; Macáková, J; Vinar, O | 1 |
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Camanni, F; Isaia, GC; Massara, F; Molinatti, GM | 1 |
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE | 1 |
Dimpfel, W; Koch, R; Schatton, W; Spüler, M | 1 |
Harvey, NS | 1 |
Alfonsi, E; Horowski, R; Martignoni, E; Nappi, G; Sandrini, G | 1 |
Accornero, N; Agnoli, A; Casacchia, M; Ruggieri, S; Volante, F | 1 |
Biesemeyer, H; Ludin, HP; Ringwald, E | 1 |
Ohtomo, E | 1 |
Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Ludolph, A; Odin, P; Oehlwein, C; Polzer, U; Renner, R; Schüler, P; Shing, M; Storch, A; Werner, G | 1 |
El Solh, AA; Saliba, R | 1 |
5 review(s) available for amantadine and ergoline
Article | Year |
---|---|
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Ergolines; gamma-Aminobutyric Acid; Humans; Lisuride; Memory Disorders; Mice; Pantothenic Acid | 1984 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Pharmacologic prevention of aspiration pneumonia: a systematic review.
Topics: Aged; Amantadine; Angiotensin-Converting Enzyme Inhibitors; Cabergoline; Capsaicin; Cilostazol; Controlled Clinical Trials as Topic; Ergolines; Humans; Pneumonia, Aspiration; Risk Factors; Sensory System Agents; Tetrazoles; Theophylline | 2007 |
4 trial(s) available for amantadine and ergoline
Article | Year |
---|---|
[Treatment of parkinsonian syndromes by bromocriptin].
Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary | 1977 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl | 1976 |
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Ergolines; gamma-Aminobutyric Acid; Humans; Lisuride; Memory Disorders; Mice; Pantothenic Acid | 1984 |
Efficacy and safety of high-dose cabergoline in Parkinson's disease.
Topics: Adolescent; Adult; Aged; Amantadine; Antiparkinson Agents; Cabergoline; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Humans; Levodopa; Middle Aged; Nitriles; Parkinson Disease; Piperidines; Prospective Studies; Quality of Life; Selegiline; Severity of Illness Index; Treatment Outcome | 2006 |
8 other study(ies) available for amantadine and ergoline
Article | Year |
---|---|
Acute effects of lisuride (0.1 mg), amantadine (100 mg) and trihexyphenidyl (5 mg) on verbal associations.
Topics: Adult; Amantadine; Association Learning; Conditioning, Operant; Ergolines; Female; Humans; Learning; Male; Trihexyphenidyl; Urea; Verbal Learning | 1978 |
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol | 1975 |
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil | 1975 |
Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Animals; Benzazepines; Brain; Corpus Striatum; Electroencephalography; Ergolines; Evoked Potentials; Frontal Lobe; Haloperidol; Hippocampus; Male; Memantine; Quinpirole; Rats; Rats, Inbred F344; Receptors, Dopamine; Reticular Formation; Synaptic Transmission; Telemetry | 1987 |
Effects of lisuride on blink reflex habituation in Parkinson disease.
Topics: Adult; Aged; Amantadine; Blinking; Electrophysiology; Ergolines; Habituation, Psychophysiologic; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1985 |
[Action of amantadine on parkinsonian tremor].
Topics: Adult; Aged; Amantadine; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Promethazine; Tremor; Trihexyphenidyl | 1971 |
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease | 1983 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |